Norges Bank Oric Pharmaceuticals, Inc. Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$23.67 - $36.85 $295,875 - $460,625	-12,500 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$20.32 - $39.8 $254,000 - $497,499	12,500 New	12,500 $423,000
Q4 2020 Feb 10, 2021	SELL	$20.32 - $39.8 $254,000 - $497,499	-12,500 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$19.5 - $31.26 $243,750 - $390,750	12,500 New	12,500 $313,000
Q3 2020 Nov 10, 2020	SELL	$19.5 - $31.26 $243,750 - $390,750	-12,500 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$25.68 - $38.12 $321,000 - $476,499	12,500 New	12,500 $422,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $325M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.